Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission

Wei-Yang LiJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China; ;Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR China

Ying WangJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China; ;Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR China

Su-Ning ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China; ;Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR China

Hui-Ying QiuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China; ;Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR China

Zheng-Zheng FuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China; ;Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR China

De-Pei WuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China; ;Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR China

Ai-Ning SunJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China; ;Suzhou Institute of Blood and Marrow Transplantation, Suzhou, PR ChinaCorrespondence[email protected]

show all

Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date